Lataa...
Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
OBJECTIVE: No standard chemotherapy is available for patients with advanced esophageal squamous cell carcinoma (ESCC) who have failed prior first-line chemotherapy. The aim of this study was to evaluate the efficacy and safety of apatinib, an oral VEGFR-2 inhibitor, as salvage treatment for advanced...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5558584/ https://ncbi.nlm.nih.gov/pubmed/28860804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S132756 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|